Organovo Holdings, Inc.
(NASDAQ : ONVO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading ONVO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.18%165.741.2%$762.85m
INCYIncyte Corporation
0.48%139.641.7%$625.40m
GILDGilead Sciences, Inc.
0.03%67.511.0%$573.84m
CELGCelgene Corporation
0.13%123.381.0%$496.94m
BIIBBiogen Inc.
-0.21%274.821.3%$454.02m
REGNRegeneron Pharmaceuticals, Inc.
2.19%373.002.1%$318.70m
KITEKite Pharma, Inc.
3.14%76.8418.8%$216.10m
ALXNAlexion Pharmaceuticals, Inc.
-0.83%119.261.6%$202.32m
TSROTESARO, Inc.
4.15%160.0016.1%$185.28m
ILMNIllumina, Inc.
1.72%170.583.7%$170.76m
ESPREsperion Therapeutics, Inc.
-3.61%38.9418.7%$166.57m
AUPHAurinia Pharmaceuticals Inc.
-4.41%8.026.3%$143.97m
CLVSClovis Oncology, Inc.
2.61%70.3217.5%$141.44m
VRTXVertex Pharmaceuticals Incorporated
1.04%89.982.2%$134.68m
EXELExelixis, Inc.
2.95%20.917.0%$105.35m

Company Profile

Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.